In search of clarity on supplements: Five myths worth busting
Myth #3: You can take them and not worry about your diet Evidence suggests that many nutrients are better absorbed through from foods than from supplements, and heat processing to make supplements sh…
#dining #cooking #diet #food #Nutrition #Aging&Geriatrics #nutrition #PrecisionHealth #preventivemedicine #StanfordMedicine #wellness
https://www.diningandcooking.com/2420759/in-search-of-clarity-on-supplements-five-myths-worth-busting/
Nam 27 tuổi đến khám vì mỏi vai, bác sĩ nghi tổn thương thần kinh trung ương, chụp MRI não phát hiện đột quỵ. Cảnh giác dấu hiệu bất thường ở vai gắn yếu tay, mặt, nói khó. #stroke #độtquy #suckhoe #nhipMA #brainhealth #preventivemedicine
https://vietnamnet.vn/thanh-nien-27-tuoi-phat-hien-dot-quy-tu-dau-hieu-o-vai-2461310.html
A groundbreaking step toward accessible and universal cancer treatment
Russian scientists have announced the development of a cancer vaccine that is ready to be provided free of charge to patients worldwide, offering a revolutionary approach to fighting one of the deadliest diseases. Unlike conventional cancer therapies that focus on treating tumors after they appear, this vaccine is designed to prime the immune system to recognize and attack cancer cells before they can spread.
The vaccine works by stimulating the body’s natural defenses to target specific cancer markers, potentially reducing the need for invasive treatments like chemotherapy or radiation. Early clinical trials have shown promising results, demonstrating both safety and effectiveness across multiple cancer types.
Experts believe that free global access to this vaccine could transform oncology, making cancer prevention and early intervention available to millions regardless of economic or geographic barriers. This initiative also underscores the potential for international cooperation in medical research and public health.
With this breakthrough, Russia positions itself at the forefront of cancer research, offering hope for a future where cancer can be prevented or managed more effectively than ever before. The announcement signals a new era in accessible and proactive healthcare.
Core discovery & research
#MedicalBreakthrough #CancerResearch #Oncology #LifeSciences #FutureOfMedicine
Treatment & technology
#CancerVaccine #Immunotherapy #PreventiveMedicine #PrecisionMedicine #NextGenHealthcare
Access & impact
#GlobalHealth #FreeHealthcare #HopeForPatients #InnovativeMedicine #HealthEquity
Jaypee Brothers Medical Publisher's #SDG03 Collection is an impressive initiative that consolidates valuable healthcare knowledge for #GlobalHealth — underscoring the significance of #PreventiveMedicine, #EmergencyCare, #WomensHealth advocacy, and #ChildHealth improvement. 🌍🩺
🔗 #JaypeeJournals on #ScienceOpen: https://www.scienceopen.com/collection/Jaypee_UNSDG03
<p>Jaypee Brothers Medical Publisher's SDG 03 Collection is an impressive initiative that consolidates valuable healthcare knowledge. It compiles journal articles from key sub-collections: "Preventive and Emergency Medicine Insights," "Maternal and Women's Health Advocacy," and "Pediatric Pulse: Advancing Neonatal and Child Health." </p>
"Manhattan Projects for Preventive Medicine" - a brand new article from Network and Systems Medicine Journal from #REPO4EU on #ScienceOpen 💊 🆕
🔬🥗 Karger: Nutrition and Dietetics centers on human #Nutrition and #Metabolism — encompassing both clinical and translational research, as well as #Diabetes, #LifestyleDiseases, and #PreventiveMedicine. 🩺
👉 https://www.scienceopen.com/collection/Karger_NutritionDietetics
🏋️♂️ What’s the molecular payoff of just one high-intensity workout?
🔗 A single HIIT session does not alter blood sphingolipid levels in healthy young adults: The SphingoHIIT randomized controlled trial. DOI: https://doi.org/10.1016/j.csbj.2025.07.004
📚 CSBJ: https://www.csbj.org/
#SportsMedicine #Metabolomics #ExerciseScience #CardiometabolicHealth #BiomedicalResearch #ClinicalTrials #HIIT #HeartHealth #PreventiveMedicine #PublicHealth #HealthInnovation #FitnessResearch #Wellbeing @csbj
<p xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" dir="auto" id="d8211345e126"> <b>Objective</b> To investigate the use of second prevention drugs and its influencing factors among patients with cardiovascular diseases at ages of 35 to 75 years in Jiangsu Province, so as to provide the scientific evidence for improving cardiovascular disease control in Jiangsu Province. </p><p xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" dir="auto" id="d8211345e131"> <b>Methods</b> Based on the data captured from Screening Program of High-risk Populations for Cardiovascular Diseases in Jiangsu Province from 2015 to 2019, a total of 3 576 patients with self-reported ischemic heart diseases and/or ischemic stroke were enrolled. Participants’ demographic features and use of second prevention drugs were collected, and the correlation between individual characteristics and use of secondary prevention drugs was examined using a multivariate mixed-effects model. </p><p xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" dir="auto" id="d8211345e136"> <b>Results</b> Of the 3 576 participants, 23.2% used statins or antiplatelet drugs, and women [odds ratio ( <i>OR</i>) = 0.59, 95% confidential interval ( <i>CI</i>): (0.47, 0.73)], current smoking [ <i>OR</i> = 0.64, 95% <i>CI</i>: (0.49, 0.82)] and current alcohol consumption [ <i>OR</i> = 0.76, 95% <i>CI</i>: (0.58, 0.99)] resulted in a lower possibility of use of statins or antiplatelet drugs, while a higher educational level [as compared to primary school and below, junior high school: <i>OR</i> = 1.72,95% <i>CI</i>: (1.35, 2.20); senior high school: <i>OR</i> = 1.75, 95% <i>CI</i>: (1.21, 2.51); university and above : <i>OR</i> =1.94, 95% <i>CI</i>: (1.06, 3.57)] and a history of hypertension [ <i>OR</i> =1.38, 95% (1.13, 1.70)] resulted in a higher possibility of use of statins or antiplatelet drugs. </p><p xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" dir="auto" id="d8211345e182"> <b>Conclusions</b> The use of secondary prevention drugs is not satisfactory among patients with cardiovascular diseases in Jiangsu Province. Females, patients with a low educational level, patients without a history of hypertension, current smokers and patients with current alcohol consumption should be given a high priority for cardiovascular disease control. </p><p xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" class="first" dir="auto" id="d8211345e188"> <b>摘要：目的</b> 评估江苏省35~75岁心血管疾病患者二级预防用药情况及影响因素, 为加强全省心血管疾病防治工作提供 科学依据。 <b>方法</b> 基于 2015—2019 年江苏省心血管病高危人群筛查项目数据, 纳人其中自报既往患有缺血性心脏病和/或 缺血性脑卒中患者, 通过问卷调查, 收集患者一般情况和用药信息, 使用多变量混合效应模型评估个体特征与二级预防用药 的相关性。 <b>结果</b> 纳人研究3 576例, 23.2% 使用他汀类或抗血小板药物；女性 ( <i>OR</i> = 0.59, 95% <i>CI</i>: 0.47 ~ 0.73)、现在吸烟 ( <i>OR</i> = 0.64, 95% <i>CI</i>: 0.49~0.82)、现在饮酒 ( <i>OR</i> = 0.76, 95% <i>CI</i>: 0.58~0.99)患者使用他汀类或抗血小板药物可能性更低；教 育水平越高(与小学及以下比较, 初中: <i>OR</i> =1.72, 95% <i>CI</i>: 1.35~2.20; 高中: <i>OR</i> =1.75, 95% <i>CI</i>: 1.21~2.51; 大学及以上: OR = 1.94, 95% <i>CI</i>: 1.06~3.57)、有高血压史 ( <i>OR</i> = 1.38, 95% <i>CI</i>: 1.13 ~ 1.70) 患者使用他汀类或抗血小板药物可能性更高。 <b>结论</b> 江苏省心血管疾病患者二级预防用药使用不太理想, 应重点关注女性、低教育水平、无高血压史、吸烟和现在饮酒患者。 </p>
<p>Based on China's health policies and public health work priorities, focused to the cutting-edge research trends in preventive medicine, <em>Jiangsu Journal of Preventive Medicine</em> timely reports the analysis, diagnosis, treatment, and control results of infectious and chronic diseases related to national economy and health. In order to provide practitioners with rich reference such as methods of analysis, surveillance and results, patents, standard interpretation, etc. In addition, we promote the communication and conversion of achievements.</p>
Dining and Cooking
Vietnamnet BOT
unitedvrg.com
Lexmilian S. R. B. de Mello
ScienceOpen
CSBJ